Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all
The analysis from Dandelion Health, a health care analytics firm, is based on the electronic health records of nearly 17,000 ...
New York Post21d
Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss ...
New York Post23d
Massive new study finds drugs like Ozempic affect 175 conditions — including a few surprises
A comprehensive new study confirmed that GLP-1 medications such as Ozempic and Mounjaro have myriad health benefits — even more than previously thought. Analyzing the medical records of roughly ...
Morningstar24d
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
In the US alone, the number of patients starting GLP-1 treatments for nondiabetic purposes has increased by 700% since 2019, highlighting the popularity of these drugs beyond their original aim of ...
pharmaphorum4d
Novo Nordisk nears EU okay for oral GLP-1 drug Rybelsus after CHMP nod
Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed ... leader in the class with sales of $4.12 billion in 2019. Lilly said last week that there was no sign yet that the ...